PTPκ Inhibitors are a class of chemical compounds that target and inhibit the activity of protein tyrosine phosphatase kappa (PTPκ), an enzyme belonging to the protein tyrosine phosphatase (PTP) family. PTPκ is a transmembrane receptor-type phosphatase that plays a critical role in cellular signaling pathways by dephosphorylating specific tyrosine residues on target proteins. This dephosphorylation process is essential for regulating various cellular functions, including cell adhesion, migration, and signaling cascades involved in cell growth and differentiation. PTPκ is particularly noted for its involvement in the regulation of cadherin-mediated cell-cell adhesion, a fundamental process in maintaining tissue architecture and integrity.
The use of PTPκ Inhibitors in research allows scientists to investigate the complex signaling networks that PTPκ influences, particularly those related to cell-cell communication and the maintenance of epithelial cell integrity. By inhibiting PTPκ activity, researchers can explore the downstream effects on cadherin-mediated adhesion and how disruptions in this process can affect cellular behavior. These inhibitors are valuable tools for studying the dynamics of cell adhesion molecules and their role in tissue morphogenesis, wound healing, and cellular response to environmental changes. Additionally, PTPκ Inhibitors provide insights into the broader regulatory mechanisms of tyrosine phosphorylation and dephosphorylation in cellular signaling networks, offering a deeper understanding of how cells coordinate their functions and maintain homeostasis. Overall, PTPκ Inhibitors are critical for advancing knowledge in cell biology, particularly in areas related to cell adhesion, signaling, and the intricate balance of phosphorylation states that govern cellular processes.
Items 1 to 10 of 16 total
Mostrar:
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | ¥282.00 ¥1320.00 ¥2358.00 | 27 | |
Inhibe la actividad de PTPR uniéndose a su sitio activo, impidiendo su actividad enzimática. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | ¥530.00 ¥1636.00 | 51 | |
Bloquea la fosforilación y activación de la PTPR, reduciendo su función de señalización. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | ¥2313.00 ¥4569.00 | 9 | |
Inhibe la actividad de la PTPR uniéndose a su dominio quinasa, impidiendo su autofosforilación. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | ¥1941.00 ¥10876.00 | 2 | |
Se dirige a la PTPR y a otras quinasas, suprimiendo su activación y la señalización posterior. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | ¥1692.00 ¥10379.00 | 5 | |
Interfiere en la señalización de la PTPR inhibiendo su fosforilación y activación. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | ¥632.00 ¥2933.00 ¥4693.00 | 129 | |
Interrumpe las cascadas de señalización mediadas por la PTPR inhibiendo su dominio quinasa. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | ¥3610.00 ¥4851.00 | 3 | |
Suprime la actividad de la PTPR bloqueando su dominio quinasa, obstaculizando los efectos posteriores. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | ¥1726.00 | 5 | |
Se dirige a la PTPR y a otras quinasas, perjudicando sus funciones de señalización. | ||||||
Acalabrutinib | 1420477-60-6 | sc-507392 | 250 mg | ¥2877.00 | ||
Inhibe la señalización de la PTPR uniéndose a su dominio quinasa e impidiendo su activación. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | ¥508.00 ¥632.00 ¥2065.00 | 142 | |
Es un conocido inhibidor no específico de las proteínas tirosina fosfatasas, que puede inhibir la actividad de la PTPR imitando el estado de transición del sustrato de la enzima. | ||||||